ARCHIVES

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011

In Brief: Hatch To Speak At AACI Dinner; NIH Plans 1987 Centennial; Cox To Head Columbia Radiotherapy

May 24, 1985

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012